Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma

被引：0

作者：

Waldschmidt, Johannes M. ^{[1
,2
,3
,4
]}

Sotudeh, Noori ^{[1
,2
,3
]}

Arora, Sankalp ^{[5
,6
]}

Vijaykumar, Tushara ^{[1
,2
]}

Anand, Praveen ^{[1
,2
,3
]}

Stuart, Hannah ^{[1
,2
,3
]}

Frede, Julia ^{[1
,2
,3
]}

Campbell, Tim ^{[7
]}

Kaiser, Shari M. ^{[7
]}

Zheng, Xirong ^{[7
]}

Munshi, Nikhil C. ^{[1
,2
]}

Anderson, Kenneth C. ^{[1
,2
]}

Einsele, Hermann ^{[4
]}

Yee, Andrew J. ^{[5
]}

Knoechel, Birgit ^{[2
,3
,8
]}

Lohr, Jens G. ^{[1
,3
]}

Raje, Noopur S. ^{[2
,3
,5
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[2] Harvard Med Sch, Boston, MA USA

[3] Broad Inst MIT & Harvard, Cambridge, MA USA

[4] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany

[5] Massachussetts Gen Hosp, Ctr Multiple Myeloma, Dept Hematol Oncol, Boston, MA USA

[6] MD ANDERSON CANC CTR, DEPT HEMATOL, HOUSTON, TX USA

[7] Bristol Myers Squibb, Princeton, NJ USA

[8] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA

来源：

BLOOD ADVANCES | 2025年 / 9卷 / 05期

关键词：

THERAPY;

D O I：

10.1182/bloodadvances.2024015285

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1132 / 1136

页数：5

共 50 条

[1] Nivolumab-Based Salvage Therapy to Restore T Cell Fitness in Penta-Refractory Multiple Myeloma with Relapse to Anti-BCMA CAR T Cell Therapy
Waldschmidt, Johannes M.
Arora, Sankalp
Vijaykumar, Tushara
Sotudeh, Noori
Anand, Praveen
Stuart, Hannah
Frede, Julia
Campbell, Tim
Kaiser, Shari M.
Lamba, Manisha
Munshi, Nikhil C.
Anderson, Kenneth C.
Yee, Andrew J.
Knoechel, Birgit
Lohr, Jens G.
Raje, Noopur
BLOOD, 2022, 140 : 9925 - 9926
[2] CAR-T Therapy in Relapsed Refractory Multiple Myeloma
Ding, Hong
Wu, Yu
CURRENT MEDICINAL CHEMISTRY, 2024, 31 (27) : 4362 - 4382
[3] CAR T-cell therapy for relapsed or refractory multiple myeloma
Stirrups, Robert
LANCET ONCOLOGY, 2019, 20 (06): : E297 - E297
[4] CAR-T cell therapy in relapsed or refractory multiple myeloma and access in Turkey
Hakan, Goker
Engin, Kelkitli
Elifcan, Karakulak Aladag
Haluk, Demiroglu
Mehmet, Turgut
Suman, Kambhampati
Maxwell, Krem
FRONTIERS IN MEDICINE, 2024, 11
[5] A new CAR-T cell therapy for multiple myeloma
Hosen, Naoki
CANCER SCIENCE, 2022, 113 : 644 - 644
[6] Development of CAR-T cell therapies for multiple myeloma
Gagelmann, Nico
Riecken, Kristoffer
Wolschke, Christine
Berger, Carolina
Ayuk, Francis A.
Fehse, Boris
Kroeger, Nicolaus
LEUKEMIA, 2020, 34 (09) : 2317 - 2332
[7] Development of CAR-T cell therapies for multiple myeloma
Nico Gagelmann
Kristoffer Riecken
Christine Wolschke
Carolina Berger
Francis A. Ayuk
Boris Fehse
Nicolaus Kröger
Leukemia, 2020, 34 : 2317 - 2332
[8] Anti-BCMA CAR-T cell immunotherapy for relapsed or refractory multiple myeloma
Zhang, Xiaohui
Ouyang, Chenxi
Sun, Guofeng
Liu, Hongfeng
Qi, Junyuan
Suo, Xiaohui
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (04)
[9] Prognostic markers for CAR-T cell therapy in patients with relapsed/refractory multiple myeloma
Liu, Yang
Yan, Zhiling
Wu, Qingyun
Chen, Chong
Cao, Jiang
Li, Zhenyu
Xu, Kailin
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S49 - S49
[10] CAR T-cell therapy for multiple myeloma
Zhou, X.
Einsele, H.
Danhof, S.
INTERNIST, 2021, 62 (06): : 605 - 610

← 1 2 3 4 5 →